Found: 10
Select item for more details and to access through your institution.
Pemetrexed-related interstitial lung disease reported from post marketing surveillance (malignant pleural mesothelioma/non-small cell lung cancer).
- Published in:
- Japanese Journal of Clinical Oncology, 2017, v. 47, n. 4, p. 350, doi. 10.1093/jjco/hyx010
- By:
- Publication type:
- Article
A phase 1 study of ramucirumab in Japanese patients with advanced solid tumors.
- Published in:
- Japanese Journal of Clinical Oncology, 2017, v. 47, n. 4, p. 298, doi. 10.1093/jjco/hyx008
- By:
- Publication type:
- Article
A phase I dose-escalation study of LY2875358, a bivalent MET antibody, given as monotherapy or in combination with erlotinib or gefitinib in Japanese patients with advanced malignancies.
- Published in:
- Investigational New Drugs, 2016, v. 34, n. 5, p. 584, doi. 10.1007/s10637-016-0370-7
- By:
- Publication type:
- Article
Pemetrexed Continuation Maintenance in Patients with Nonsquamous Non-small Cell Lung Cancer: Review of Two East Asian Trials in Reference to PARAMOUNT.
- Published in:
- Cancer Research & Treatment, 2015, v. 47, n. 3, p. 424, doi. 10.4143/crt.2013.266
- By:
- Publication type:
- Article
Phase I study of the second-generation, recombinant, human EGFR antibody necitumumab in Japanese patients with advanced solid tumors.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Overexpression of IQGAP1 in advanced colorectal cancer correlates with poor prognosis-critical role in tumor invasion.
- Published in:
- International Journal of Cancer, 2010, v. 126, n. 11, p. 2563, doi. 10.1002/ijc.24987
- By:
- Publication type:
- Article
Fatty acid synthase is a novel therapeutic target in multiple myeloma.
- Published in:
- British Journal of Haematology, 2008, v. 141, n. 5, p. 659, doi. 10.1111/j.1365-2141.2008.07114.x
- By:
- Publication type:
- Article
Abemaciclib in combination with endocrine therapy for East Asian patients with HR+, HER2− advanced breast cancer: MONARCH 2 & 3 trials.
- Published in:
- Cancer Science, 2021, v. 112, n. 6, p. 2381, doi. 10.1111/cas.14877
- By:
- Publication type:
- Article
Ramucirumab or placebo plus erlotinib in EGFR‐mutated, metastatic non‐small‐cell lung cancer: East Asian subset of RELAY.
- Published in:
- Cancer Science, 2020, v. 111, n. 12, p. 4510, doi. 10.1111/cas.14655
- By:
- Publication type:
- Article
Patients' preferences for postmenopausal hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer treatments in Japan.
- Published in:
- Breast Cancer (13406868), 2019, v. 26, n. 5, p. 652, doi. 10.1007/s12282-019-00965-4
- By:
- Publication type:
- Article